Literature DB >> 18241031

Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.

Marianna Ofner-Agostini1, B Lynn Johnston, Andrew E Simor, John Embil, Anne Matlow, Michael Mulvey, Debbie Ormiston, John Conly.   

Abstract

Surveillance for vancomycin-resistant enterococci (VRE) in sentinel Canadian hospitals has been conducted since 1999. From 1999 to 2005, the rate of VRE detection increased from 0.37 to 1.32 cases per 1,000 patients admitted, and the rate of VRE infection increased from 0.02 to 0.05 cases per 1,000 patients admitted. Thirty-three percent of all patients with VRE detected that were reported during 1999-2005 were identified in 2005, with increases seen in all regions of Canada. Although the incidence rate of VRE carriage in Canada is increasing, it remains very low.

Entities:  

Mesh:

Year:  2008        PMID: 18241031     DOI: 10.1086/528812

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

Review 1.  Prevention and control of infections in the home.

Authors:  John M Embil; Brenda Dyck; Pierre Plourde
Journal:  CMAJ       Date:  2009-05-26       Impact factor: 8.262

Review 2.  Antimicrobial resistance in hospitals: how concerned should we be?

Authors:  Michael R Mulvey; Andrew E Simor
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

Review 3.  Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  B Lynn Johnston; Elizabeth Bryce
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

4.  Antimicrobial resistance surveillance systems: Are potential biases taken into account?

Authors:  Olivia Rempel; Johann Dd Pitout; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

5.  Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study.

Authors:  Rachel D Savage; Robert A Fowler; Asgar H Rishu; Sean M Bagshaw; Deborah Cook; Peter Dodek; Richard Hall; Anand Kumar; François Lamontagne; François Lauzier; John Marshall; Claudio M Martin; Lauralyn McIntyre; John Muscedere; Steven Reynolds; Henry T Stelfox; Nick Daneman
Journal:  CMAJ Open       Date:  2016-10-13

6.  Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene.

Authors:  Tom A Szakacs; Lindsay Kalan; Michael J McConnell; Alireza Eshaghi; Dea Shahinas; Allison McGeer; Gerry D Wright; Donald E Low; Samir N Patel
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

7.  Novel chromogenic medium for detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

Authors:  Gaëlle Cuzon; Thierry Naas; Nicolas Fortineau; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

8.  Cefazolin use in patients who report a non-IgE mediated penicillin allergy: a retrospective look at adverse reactions in arthroplasty.

Authors:  S Haslam; D Yen; N Dvirnik; D Engen
Journal:  Iowa Orthop J       Date:  2012

9.  Prevalence of positive carriage of tuberculosis, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant Enterococci in patients transported by ambulance: a single center observational study.

Authors:  Young Sun Ro; Sang Do Shin; Hyun Noh; Sung-Il Cho
Journal:  J Prev Med Public Health       Date:  2012-05-31

10.  Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009.

Authors:  Geoffrey Taylor; Denise Gravel; Lynora Saxinger; Kathryn Bush; Kimberley Simmonds; Anne Matlow; Joanne Embree; Nicole Le Saux; Lynn Johnston; Kathryn N Suh; John Embil; Elizabeth Henderson; Michael John; Virginia Roth; Alice Wong
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Mar-Apr       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.